LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Your last searches

  1. TI=SARS CoV 2 seroprevalence trends in healthy blood donors during the COVID 19 outbreak in Milan
  2. TI=Endodontic Emergencies in Mumbai City during COVID 19 Lockdown and Different Phases of Unlock

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 outbreak in Milan.

    Valenti, Luca / Bergna, Annalisa / Pelusi, Serena / Facciotti, Federica / Lai, Alessia / Tarkowski, Maciej / Lombardi, Angela / Berzuini, Alessandra / Caprioli, Flavio / Santoro, Luigi / Baselli, Guido / Ventura, Carla Della / Erba, Elisa / Bosari, Silvano / Galli, Massimo / Zehender, Gianguglielmo / Prati, Daniele

    Blood transfusion = Trasfusione del sangue

    2021  Volume 19, Issue 3, Page(s) 181–189

    Abstract: ... by the SARS-CoV-2 outbreak. The aim of this study was to examine the seroprevalence trends of SARS-CoV-2 ... At the start of the outbreak, the overall adjusted seroprevalence of SARS-CoV-2 was 2.7% (95% CI: 0.3-6%; p<0 ... CI: 2.8-8.2; p=0.004 for trend), but there was no increase in IgM: Discussion: SARS-CoV-2 ...

    Abstract Background: The Milan metropolitan area in Northern Italy was among the most severely hit by the SARS-CoV-2 outbreak. The aim of this study was to examine the seroprevalence trends of SARS-CoV-2 in healthy asymptomatic adults, and the risk factors and laboratory correlates of positive tests.
    Materials and methods: We conducted a cross-sectional study in a random sample of blood donors, who were asymptomatic at the time of evaluation, at the beginning of the first phase (February 24
    Results: The test had a 100/98.3 sensitivity/specificity (n=32/120 positive/negative controls, respectively), and the IgG test was validated in a subset by an independent ELISA against the Spike protein (n=34, p<0.001). At the start of the outbreak, the overall adjusted seroprevalence of SARS-CoV-2 was 2.7% (95% CI: 0.3-6%; p<0.0001 vs 120 historical controls). During the study period, characterised by a gradual implementation of social distancing measures, there was a progressive increase in the adjusted seroprevalence to 5.2% (95% CI: 2.4-9.0; 4.5%, 95% CI: 0.9-9.2% according to a Bayesian estimate) due to a rise in IgG reactivity to 5% (95% CI: 2.8-8.2; p=0.004 for trend), but there was no increase in IgM
    Discussion: SARS-CoV-2 infection was already circulating in Milan at the start of the outbreak. The pattern of IgM/IgG reactivity was influenced by age: IgM was more frequently detected in participants aged >45 years. By the end of April, 2.4-9.0% of healthy adults had evidence of seroconversion.
    MeSH term(s) Adult ; Age Factors ; Antibodies, Viral/blood ; Asymptomatic Infections/epidemiology ; Bayes Theorem ; Blood Donors/statistics & numerical data ; COVID-19/epidemiology ; COVID-19/immunology ; COVID-19 Serological Testing/methods ; Confidence Intervals ; Cross-Sectional Studies ; Female ; Humans ; Immunoglobulin G/blood ; Immunoglobulin M/blood ; Italy/epidemiology ; Male ; Middle Aged ; Pandemics ; Regression Analysis ; Risk Factors ; SARS-CoV-2/immunology ; Seroconversion ; Seroepidemiologic Studies ; Spike Glycoprotein, Coronavirus/immunology
    Chemical Substances Antibodies, Viral ; Immunoglobulin G ; Immunoglobulin M ; Spike Glycoprotein, Coronavirus ; spike glycoprotein, SARS-CoV
    Language English
    Publishing date 2021-02-03
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 2135732-8
    ISSN 2385-2070 ; 0041-1787 ; 1723-2007
    ISSN (online) 2385-2070
    ISSN 0041-1787 ; 1723-2007
    DOI 10.2450/2021.0324-20
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 Milan outbreak

    Valenti, L. / Bergna, A. / Pelusi, S. / Facciotti, F. / Lai, A. / Tarkowski, M. / Berzuini, A. / Caprioli, F. / Santoro, L. / Baselli, G. / Della Ventura, C. / Erba, E. / Bosari, S. / Galli, M. / Zehender, G. / Prati, D.

    Abstract: ... by the SARS-CoV-2 outbreak. The epidemiological trends of mild COVID-19 are however still unknown. The aim ... of this study was to examine the seroprevalence of SARS-CoV-2 infection in healthy asymptomatic adults ... At the start of the outbreak, the overall seroprevalence of SARS-CoV-2 was 4.6% (2.3 to 7.9; P<0.0001 vs. 120 ...

    Abstract Objectives: The Milan metropolitan area in Northern Italy was among the most severely hit by the SARS-CoV-2 outbreak. The epidemiological trends of mild COVID-19 are however still unknown. The aim of this study was to examine the seroprevalence of SARS-CoV-2 infection in healthy asymptomatic adults, the risk factors, and laboratory correlates. Design: We conducted a cross-sectional study during the outbreak. Presence of anti-SARS-CoV-2 IgM/IgG antibodies against the Nucleocapsid protein was assessed by a lateral flow immunoassay. Setting: Blood center at a leading academic hospital serving as COVID-19 referral center. Participants: We considered a random sample of blood donors since the start of the outbreak (February 24th to April 8th 2020, n=789). Main outcome measures: The main outcome was the prevalence of IgG/IgM anti-SARS-CoV-2 antibodies . Results: The test had a 98.3% specificity and 100% sensitivity, and for IgG was validated in a subset by an independent ELISA against the Spike protein (N=34, P<0.001). At the start of the outbreak, the overall seroprevalence of SARS-CoV-2 was 4.6% (2.3 to 7.9; P<0.0001 vs. 120 historical controls). During the study period characterized by a gradual implementation of social distancing measures, there was a progressive increase in seroprevalence to 7.1% (4.4 to 10.8), due to a rise in IgG+ to 5% (2.8 to 8.2; P=0.004 for trend, adjusted weekly increase 2.7, SE 1.3%), but not of IgM+ (P=NS). At multivariate logistic regression analysis, seroconversion to IgG was more frequent in younger (P=0.043), while recent infections (IgM+) in older individuals (P=0.002). IgM+ was independently associated with higher triglycerides, eosinophils, and lymphocytes (P<0.05). Conclusions: SARS-CoV-2 infection was already circulating in Milan at the outbreak start. Social distancing may have been more effective in younger individuals, and by the end of April 4.4-10.8% of healthy adults had evidence of seroconversion. Asymptomatic infection may affect lipid profile and blood count.
    Keywords covid19
    Publisher MedRxiv; WHO
    Document type Article ; Online
    DOI 10.1101/2020.05.11.20098442
    Database COVID19

    Kategorien

  3. Article ; Online: SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 Milan outbreak

    Valenti, Luca / Bergna, Annalisa / Pelusi, Serena / Facciotti, Federica / Lai, Alessia / Tarkowski, Maciej / Berzuini, Alessandra / Caprioli, Flavio / Santoro, Luigi / Baselli, Guido / Della Ventura, Carla / Erba, Elisa / Bosari, Silvano / Galli, Massimo / Zehender, Gianguglielmo / Prati, Daniele

    medRxiv

    Abstract: ... by the SARS-CoV-2 outbreak. The epidemiological trends of mild COVID-19 are however still unknown. The aim ... of this study was to examine the seroprevalence of SARS-CoV-2 infection in healthy asymptomatic adults ... At the start of the outbreak, the overall seroprevalence of SARS-CoV-2 was 4.6% (2.3 to 7.9; P<0.0001 vs. 120 ...

    Abstract Objectives: The Milan metropolitan area in Northern Italy was among the most severely hit by the SARS-CoV-2 outbreak. The epidemiological trends of mild COVID-19 are however still unknown. The aim of this study was to examine the seroprevalence of SARS-CoV-2 infection in healthy asymptomatic adults, the risk factors, and laboratory correlates. Design: We conducted a cross-sectional study during the outbreak. Presence of anti-SARS-CoV-2 IgM/IgG antibodies against the Nucleocapsid protein was assessed by a lateral flow immunoassay. Setting: Blood center at a leading academic hospital serving as COVID-19 referral center. Participants: We considered a random sample of blood donors since the start of the outbreak (February 24th to April 8th 2020, n=789). Main outcome measures: The main outcome was the prevalence of IgG/IgM anti-SARS-CoV-2 antibodies . Results: The test had a 98.3% specificity and 100% sensitivity, and for IgG was validated in a subset by an independent ELISA against the Spike protein (N=34, P<0.001). At the start of the outbreak, the overall seroprevalence of SARS-CoV-2 was 4.6% (2.3 to 7.9; P<0.0001 vs. 120 historical controls). During the study period characterized by a gradual implementation of social distancing measures, there was a progressive increase in seroprevalence to 7.1% (4.4 to 10.8), due to a rise in IgG+ to 5% (2.8 to 8.2; P=0.004 for trend, adjusted weekly increase 2.7, SE 1.3%), but not of IgM+ (P=NS). At multivariate logistic regression analysis, seroconversion to IgG was more frequent in younger (P=0.043), while recent infections (IgM+) in older individuals (P=0.002). IgM+ was independently associated with higher triglycerides, eosinophils, and lymphocytes (P<0.05). Conclusions: SARS-CoV-2 infection was already circulating in Milan at the outbreak start. Social distancing may have been more effective in younger individuals, and by the end of April 4.4-10.8% of healthy adults had evidence of seroconversion. Asymptomatic infection may affect lipid profile and blood count.
    Keywords covid19
    Language English
    Publishing date 2020-05-18
    Publisher Cold Spring Harbor Laboratory Press
    Document type Article ; Online
    DOI 10.1101/2020.05.11.20098442
    Database COVID19

    Kategorien

To top